Search

Search Constraints

You searched for: Author/Creator Ward, Tim

Search Results

1. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer. (September 2019)

2. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer. (March 2022)

3. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study. (November 2022)

4. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). (April 2022)

5. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity. (June 2021)

8. A whole of systems approach to improved understanding of the environmental, economic and social values of a frontier marine oil and gas field: Establishment, success factors and lessons learnt. (November 2018)

9. Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement. Issue 3 (December 2016)

10. Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma. Issue 5 (24th June 2013)